Treatment-Resistant Schizophrenia in a Patient With 17q12 Duplication

Biol Psychiatry. 2016 Aug 15;80(4):e19-e20. doi: 10.1016/j.biopsych.2015.10.001. Epub 2015 Oct 8.

Authors

Maria Rogdaki¹, Sameer Jauhar², Robert McCutcheon², Oliver Howes³

Affiliations

¹ Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College. Electronic address: [email protected].
² Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College.
³ Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College; Psychiatric Imaging, MRC Clinical Sciences Centre, Hammersmith Hospital, London, United Kingdom.

PMID: 26582588
DOI: 10.1016/j.biopsych.2015.10.001

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Amisulpride
Antipsychotic Agents / adverse effects
Chromosomes, Human, Pair 17 / genetics
Drug Resistance / genetics
Humans
Male
Mosaicism
Psychiatric Status Rating Scales
Schizophrenia / drug therapy
Schizophrenia / genetics*
Sulpiride / adverse effects
Sulpiride / analogs & derivatives
Trisomy / genetics*
Young Adult

Substances

Antipsychotic Agents
Sulpiride
Amisulpride

Supplementary concepts

Chromosome 17 trisomy

Grants and funding